Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 1264

1.

Prospective study on the potential of RAAS blockade to halt renal disease in Alport syndrome patients with heterozygous mutations.

Stock J, Kuenanz J, Glonke N, Sonntag J, Frese J, Tönshoff B, Höcker B, Hoppe B, Feldkötter M, Pape L, Lerch C, Wygoda S, Weber M, Müller GA, Gross O.

Pediatr Nephrol. 2016 Jul 11. [Epub ahead of print]

PMID:
27402170
2.

[Adrenomedullin in the kidney: physiology and pathophysiology].

Sogbe-Díaz ME, Díaz-López EE.

Invest Clin. 2016 Mar;57(1):66-76. Spanish.

PMID:
27382803
3.

Predictors of CKD and rate of decline in eGFR in the elderly: A case-cohort study.

Ghaffar U, Maharjan N, Moore PC.

Nephrol News Issues. 2016 Apr;30(4):38-45.

PMID:
27257659
4.

Baseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry).

Reinecke H, Breithardt G, Engelbertz C, Schmieder RE, Fobker M, Pinnschmidt HO, Schmitz B, Bruland P, Wegscheider K, Pavenstädt H, Brand E.

PLoS One. 2016 Feb 9;11(2):e0148057. doi: 10.1371/journal.pone.0148057. eCollection 2016.

5.

Sodium-Glucose Linked Cotransporter-2 Inhibition Does Not Attenuate Disease Progression in the Rat Remnant Kidney Model of Chronic Kidney Disease.

Zhang Y, Thai K, Kepecs DM, Gilbert RE.

PLoS One. 2016 Jan 7;11(1):e0144640. doi: 10.1371/journal.pone.0144640. eCollection 2016.

6.

[Kidney Disease and Laboratory Examinations--Opening Remarks: For Better Understanding of CKD].

Yoshida H, Wada T.

Rinsho Byori. 2015 Feb;63(2):250-1. Japanese.

PMID:
26529978
7.

Impact of Reduced Glomerular Filtration Rate and Proteinuria on Overall Survival of Patients with Renal Cancer.

Tourojman M, Kirmiz S, Boelkins B, Noyes SL, Davis AT, O'Donnell K, Tobert CM, Lane BR.

J Urol. 2016 Mar;195(3):588-93. doi: 10.1016/j.juro.2015.09.083. Epub 2015 Nov 30.

PMID:
26433140
8.

Albuminuria as a Risk Factor for Anemia in Chronic Kidney Disease: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD).

Han JS, Lee MJ, Park KS, Han SH, Yoo TH, Oh KH, Park SK, Lee J, Hyun YY, Chung W, Kim YH, Ahn C, Choi KH.

PLoS One. 2015 Oct 2;10(10):e0139747. doi: 10.1371/journal.pone.0139747. eCollection 2015.

9.

Acute Kidney Injury and CKD: No Respite for a Weary Kidney.

Palant C, Amdur R, Chawla LS.

Am J Kidney Dis. 2015 Oct;66(4):552-4. doi: 10.1053/j.ajkd.2015.08.014. No abstract available.

PMID:
26408233
10.

Spectrum of IgA nephropathy in a single center.

Das U, Dakshinamurty KV, Prayaga A, Uppin M.

Saudi J Kidney Dis Transpl. 2015 Sep;26(5):1057-63. doi: 10.4103/1319-2442.164612.

11.

Diabetic kidney disease and vascular comorbidities in patients with type 2 diabetes mellitus in a developing country.

Bentata Y, Chemlal A, Karimi I, El Alaoui F, Haddiya I, Abouqal R.

Saudi J Kidney Dis Transpl. 2015 Sep;26(5):1035-43. doi: 10.4103/1319-2442.164602.

12.

Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.

Mohamed R, Jayakumar C, Chen F, Fulton D, Stepp D, Gansevoort RT, Ramesh G.

J Am Soc Nephrol. 2016 Mar;27(3):745-65. doi: 10.1681/ASN.2014111136. Epub 2015 Sep 2.

PMID:
26334030
13.

Primary Care of the Patient with Chronic Kidney Disease.

Kiefer MM, Ryan MJ.

Med Clin North Am. 2015 Sep;99(5):935-52. doi: 10.1016/j.mcna.2015.05.003. Review.

PMID:
26320040
14.

Albuminuria and Glomerular Filtration in Patients with Essential Hypertension.

Mihajlov R, Stoeva D, Pencheva B, Bogusheva E, Ruseva A, Gencheva-Angelova I.

Clin Lab. 2015;61(7):677-85.

PMID:
26299065
15.

Paediatric chronic kidney disease.

van Biljon I, Meyers AM.

S Afr Med J. 2015 Apr;105(4):316-9. Review.

PMID:
26294878
16.

Midterm Outcome of Living-Related Kidney Transplantation From Aged Donors: A Single-Center Experience.

Cheng K, Huang Z, Ye Q, Ming Y, Zhao Y, Liu L, Zhang S, Chen Z, Wang Q.

Transplant Proc. 2015 Jul-Aug;47(6):1736-40. doi: 10.1016/j.transproceed.2015.06.016.

PMID:
26293043
17.

A systematic review of the predictors of disease progression in patients with autosomal dominant polycystic kidney disease.

Woon C, Bielinski-Bradbury A, O'Reilly K, Robinson P.

BMC Nephrol. 2015 Aug 15;16:140. doi: 10.1186/s12882-015-0114-5. Review.

18.

Kidney Function and Fracture Risk: The Atherosclerosis Risk in Communities (ARIC) Study.

Daya NR, Voskertchian A, Schneider AL, Ballew S, McAdams DeMarco M, Coresh J, Appel LJ, Selvin E, Grams ME.

Am J Kidney Dis. 2016 Feb;67(2):218-26. doi: 10.1053/j.ajkd.2015.06.020. Epub 2015 Aug 4.

PMID:
26250781
19.

Immunosuppressive agents for treating IgA nephropathy.

Vecchio M, Bonerba B, Palmer SC, Craig JC, Ruospo M, Samuels JA, Molony DA, Schena FP, Strippoli GF.

Cochrane Database Syst Rev. 2015 Aug 3;(8):CD003965. doi: 10.1002/14651858.CD003965.pub2. Review.

PMID:
26235292
20.

Influence of chronic kidney disease on cardiac structure and function.

Matsushita K, Ballew SH, Coresh J.

Curr Hypertens Rep. 2015 Sep;17(9):581. doi: 10.1007/s11906-015-0581-x. Review.

PMID:
26194332
Items per page

Supplemental Content

Loading ...
Write to the Help Desk